LISINOPRIL-GA lisinopril 2.5mg (as dihydrate) tablet blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

lisinopril dihydrate (Equivalent: lisinopril, Qty 2.5 mg)

Verfügbar ab:

Medis Pharma Pty Ltd

INN (Internationale Bezeichnung):

Lisinopril dihydrate

Darreichungsform:

Tablet, uncoated

Zusammensetzung:

Excipient Ingredients: mannitol; calcium hydrogen phosphate dihydrate; maize starch; magnesium stearate

Verabreichungsweg:

Oral

Einheiten im Paket:

100, 28 tablets, 14, 30 tablets, 56 tablets, 10, 84 tablets, 50

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Hypertension: For treatment of hypertension, lisinopril may be used alone or concomitantly with other classes of antihypertensive agents. Sufficient data have not been provided to support the use of lisinopril in severe hypertension or renovascular hypertension. Congestive heart failure: For treatment of heart failure, it is recommended that lisinopril be administered with a diuretic. Acute myocardial infarction: For treatment of acute myocardial infarction in haemodynamically stable patients, defined as patients who are not in cardiogenic shock and who have a systolic blood pressure greater than 100 mmHg, lisinopril may be initiated within 24 hours of an acute myocardial infarction.

Produktbesonderheiten:

Visual Identification: White to almost white, circular, biconvex, uncoated tablets with '2.5' embossing on one side and 'BL' embossing on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Registered

Berechtigungsdatum:

2006-07-27